Meaidi A

No ORCID on file · 7 papers in corpus
observational 2026
PLoS medicine ·doi:10.1371/journal.pmed.1004652

BACKGROUND: Sex hormones have been implicated in leukemogenesis, but evidence regarding hormonal contraceptive use and leukemia risk remains limited and primarily based on older formulations. Given the widespread use of contemporary hormona…

other 2025
JAMA ·doi:10.1001/jama.2024.28778
observational 2025
American journal of ophthalmology ·doi:10.1016/j.ajo.2025.05.027

PURPOSE: To investigate the association between hormonal contraceptive use and the risk of retinal vascular occlusions in women of reproductive age. DESIGN: Register-based, nationwide cohort study. PARTICIPANTS: A total of 2,208,172 women…

other 2024
JAMA ·doi:10.1001/jama.2024.18575
observational 2024
The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2023.100813

BACKGROUND: Use of the high-dose levonorgestrel-releasing intrauterine system (LNG-IUS) has been associated with increased risk of incident depression. Evidence is lacking on the influence of use of two recently marketed low-dose LNG-IUS on…

other 2023
JAMA ·doi:10.1001/jama.2023.0380
observational 2021
EClinicalMedicine ·doi:10.1016/j.eclinm.2021.100882

BACKGROUND: Oral tranexamic acid is effective for heavy menstrual bleeding, but the thrombosis risk with this treatment is largely not studied. METHODS: Using nationwide registries, we assessed associations between use of oral tranexamic a…